title: Differential toxicity of DNA adducts of mitomycin C.
abstract: The clinically used antitumor agent mitomycin C (MC) alkylates DNA upon reductive activation, forming six covalent DNA adducts in this process. This paper focuses on differential biological effects of individual adducts in various mammalian cell cultures, observed in the authors' laboratories. Evidence is reviewed that various adducts are capable of inducing different cell death pathways in cancer cells. This evidence is derived from a parallel study of MC and its derivatives 2,7-diaminomitosene (2,7-DAM) which is the main metabolite of MC and forms two monoadducts with DNA, and decarbamoyl mitomycin C (DMC), which alkylates and crosslinks DNA, predominantly with a chirality opposite to that of the DNA adducts of MC. Specifically, 2,7-DAM is not cytotoxic and does not activate the p53 pathway while MC and DMC are cytotoxic and able to activate the p53 pathway. DMC is more cytotoxic than MC and can also kill p53-deficient cells by inducing degradation of Checkpoint 1 protein, which is not seen with MC treatment of the p53-deficient cells. This difference in the cell death pathways activated by the MC and DMC is attributed to differential signaling by the DNA adducts of DMC. We hypothesize that the different chirality of the adduct-to-DNA linkage has a modulating influence on the choice of pathway. Future studies will be directed to elucidate mechanisms of MC- and DMC-DNA adduct signaling in a structure-dependent context.
authors.affiliation: Department of Science, John Jay College, The City University of New York, New York, NY 10019, USA.
authors.forename: Jill
authors.initials: J
authors.lastname: Bargonetti
authors.forename: Elise
authors.initials: E
authors.lastname: Champeil
authors.forename: Maria
authors.initials: M
authors.lastname: Tomasz
references.citation: Chem Res Toxicol. 2000 Jun;13(6):479-88
references.pmid: 10858321
references.citation: J Med Chem. 1971 Feb;14(2):109-12
references.pmid: 4993458
references.citation: Biochem Pharmacol. 2001 Jun 15;61(12):1517-29
references.pmid: 11377381
references.citation: J Biol Chem. 2002 Oct 25;277(43):40513-9
references.pmid: 12183457
references.citation: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S16-22
references.pmid: 14508077
references.citation: Genes Dev. 2000 Jun 15;14(12):1448-59
references.pmid: 10859164
references.citation: Cell. 2009 May 1;137(3):413-31
references.pmid: 19410540
references.citation: Cell. 2008 May 30;133(5):864-77
references.pmid: 18510930
references.citation: Oncol Res. 1998;10(10):509-21
references.pmid: 10338154
references.citation: Cancer Cell. 2007 Feb;11(2):175-89
references.pmid: 17292828
references.citation: Biochemistry. 1993 May 11;32(18):4708-18
references.pmid: 8490017
references.citation: Biochemistry. 1981 Aug 18;20(17):5056-61
references.pmid: 6794605
references.citation: Mutat Res. 1979 Nov;63(1):175-88
references.pmid: 522865
references.citation: Mol Cell. 2009 Sep 11;35(5):716-23
references.pmid: 19748364
references.citation: Mol Cell. 2009 Sep 11;35(5):704-15
references.pmid: 19748363
references.citation: Oncol Res. 1995;7(1):39-47
references.pmid: 7549043
references.citation: Mol Cell. 2005 Sep 2;19(5):607-18
references.pmid: 16137618
references.citation: Chem Biol. 1995 Sep;2(9):575-9
references.pmid: 9383461
references.citation: Cancer Res. 1990 Aug 1;50(15):4692-7
references.pmid: 2114946
references.citation: Chem Res Toxicol. 2005 Feb;18(2):213-23
references.pmid: 15720125
references.citation: J Antibiot (Tokyo). 1956 Jul;9(4):141-6
references.pmid: 13385186
references.citation: Chem Res Toxicol. 2008 Dec;21(12):2370-8
references.pmid: 19053323
references.citation: ACS Chem Biol. 2007 Jun 15;2(6):399-407
references.pmid: 17530733
references.citation: Chem Res Toxicol. 2010 Jul 19;23(7):1151-62
references.pmid: 20536192
references.citation: Chem Res Toxicol. 2002 Nov;15(11):1398-406
references.pmid: 12437330
references.citation: Science. 2008 Mar 7;319(5868):1352-5
references.pmid: 18323444
references.citation: Proc Natl Acad Sci U S A. 1963 Aug;50:355-62
references.pmid: 14060656
references.citation: Chem Res Toxicol. 1998 Jan;11(1):64-9
references.pmid: 9477227
references.citation: Science. 1987 Mar 6;235(4793):1204-8
references.pmid: 3103215
references.citation: Eur J Cancer. 1995 Nov;31A(12):1928-33
references.pmid: 8562144